These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33731067)
1. Role of insulin-like growth factor 1, sex and corticosteroid hormones in male major depressive disorder. Arinami H; Suzuki Y; Tajiri M; Tsuneyama N; Someya T BMC Psychiatry; 2021 Mar; 21(1):157. PubMed ID: 33731067 [TBL] [Abstract][Full Text] [Related]
2. Hormonal Dynamics Effect of Serum Insulin-Like Growth Factor I and Cortisol/Dehydroepiandrosterone Sulfate Ratio on Symptom Severity of Major Depressive Disorder. Tajiri M; Suzuki Y; Tsuneyama N; Arinami H; Someya T J Clin Psychopharmacol; 2019; 39(4):367-371. PubMed ID: 31211752 [TBL] [Abstract][Full Text] [Related]
3. Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls. Matsuzaka H; Maeshima H; Kida S; Kurita H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H Int J Psychiatry Med; 2013; 46(2):203-21. PubMed ID: 24552043 [TBL] [Abstract][Full Text] [Related]
4. DHEAS and cortisol/DHEAS-ratio in recurrent depression: State, or trait predicting 10-year recurrence? Mocking RJ; Pellikaan CM; Lok A; Assies J; Ruhé HG; Koeter MW; Visser I; Bockting CL; Olff M; Schene AH Psychoneuroendocrinology; 2015 Sep; 59():91-101. PubMed ID: 26036454 [TBL] [Abstract][Full Text] [Related]
5. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls. Jin RO; Mason S; Mellon SH; Epel ES; Reus VI; Mahan L; Rosser RL; Hough CM; Burke HM; Mueller SG; Wolkowitz OM Psychoneuroendocrinology; 2016 Oct; 72():139-46. PubMed ID: 27428086 [TBL] [Abstract][Full Text] [Related]
6. Cortisol, dehydroepiandrosterone sulfate, fatty acids, and their relation in recurrent depression. Ter Horst DM; Schene AH; Figueroa CA; Assies J; Lok A; Bockting CLH; Ruhé HG; Mocking RJT Psychoneuroendocrinology; 2019 Feb; 100():203-212. PubMed ID: 30388594 [TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism. Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442 [TBL] [Abstract][Full Text] [Related]
8. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder]. Ozsoy S; Eşel E; Hacimusalar Y; Candan Z; Kula M; Turan T Turk Psikiyatri Derg; 2008; 19(4):341-8. PubMed ID: 19110975 [TBL] [Abstract][Full Text] [Related]
9. Impact of adrenal hormones, reproductive aging, and major depression on memory circuitry decline in early midlife. Konishi K; Cherkerzian S; Jacobs EG; Richards C; Remington A; Aizley H; Misra M; Lasley BL; Goldstein JM Brain Res; 2019 Oct; 1721():146303. PubMed ID: 31279842 [TBL] [Abstract][Full Text] [Related]
10. Cerebral perfusion in depression: Relationship to sex, dehydroepiandrosterone sulfate and depression severity. Ritter C; Buchmann A; Müller ST; Hersberger M; Haynes M; Ghisleni C; Tuura R; Hasler G Neuroimage Clin; 2021; 32():102840. PubMed ID: 34628302 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum dehydroepiandrosterone sulfate, androstenedione, and sex hormones in men and women. Phillips GB Eur J Endocrinol; 1996 Feb; 134(2):201-6. PubMed ID: 8630520 [TBL] [Abstract][Full Text] [Related]
12. Serum cortisol and insulin-like growth factor 1 levels in major depressive disorder and schizophrenia. Arinami H; Watanabe Y; Suzuki Y; Tajiri M; Tsuneyama N; Someya T Sci Rep; 2023 Jan; 13(1):1148. PubMed ID: 36670169 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine abnormalities associated with untreated first episode patients with major depressive disorder and bipolar disorder. Feng G; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Fan X; Yang J Psychoneuroendocrinology; 2019 Sep; 107():119-123. PubMed ID: 31125758 [TBL] [Abstract][Full Text] [Related]
14. Plasma testosterone and dehydroepiandrosterone sulfate in male and female patients with dysthymic disorder. Markianos M; Tripodianakis J; Sarantidis D; Hatzimanolis J J Affect Disord; 2007 Aug; 101(1-3):255-8. PubMed ID: 17182106 [TBL] [Abstract][Full Text] [Related]
15. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Kurita H; Maeshima H; Kida S; Matsuzaka H; Shimano T; Nakano Y; Baba H; Suzuki T; Arai H J Affect Disord; 2013 Apr; 146(2):205-12. PubMed ID: 23102506 [TBL] [Abstract][Full Text] [Related]
16. Association of serum cortisol and dehydroepiandrosterone sulfate (DHEAS) levels with psychological stress in patients with vitiligo. Gürpınar A; Doğan Günaydın S; Kılıç C; Karaduman A Turk J Med Sci; 2019 Jun; 49(3):832-837. PubMed ID: 31203593 [TBL] [Abstract][Full Text] [Related]
17. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192 [TBL] [Abstract][Full Text] [Related]
18. Negative correlation between negative symptoms of schizophrenia and testosterone levels. Goyal RO; Sagar R; Ammini AC; Khurana ML; Alias AG Ann N Y Acad Sci; 2004 Dec; 1032():291-4. PubMed ID: 15677432 [TBL] [Abstract][Full Text] [Related]
19. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. Vermeulen A; Kaufman JM; Giagulli VA J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841 [TBL] [Abstract][Full Text] [Related]
20. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Cleare AJ; O'Keane V; Miell JP Psychoneuroendocrinology; 2004 Jul; 29(6):724-32. PubMed ID: 15110921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]